PRA Health Sciences
Search results
1 day ago · ICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.
ICON plc | 525,784 followers on LinkedIn. Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save...
About ICON. Healthcare Intelligence. Clinical Research. Evolved. Play. Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life.
ICON plc is an Irish headquartered Nasdaq listed multinational healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry.
2 days ago · ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve ...
ICON is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations.
Feb 22, 2022 · Full year net business wins of $6,958 million; a net book to bill of 1.27. Closing backlog of $19.1 billion, an increase of 2.6% on Q3 2021 or an increase of 9.5% year over year on a Combined Company basis. Quarter 4 adjusted revenue of $1,881.1 million representing a year on year increase of 147.4%.
Full year net business wins of $6,958 million; a net book to bill of 1.27. Closing backlog of $19.1 billion, an increase of 2.6% on Q3 2021 or an increase of 9.5% year over year on a Combined Company basis. Quarter 4 adjusted revenue of $1,881.1 million representing a year on year increase of 147.4%.
May 30, 2024 · ICON is updating its full-year 2024 guidance to incorporate its recent debt refinancing, including the impact of the successful $2 billion investment grade bond offering closed in early May, as well as the repricing in March of the existing Term Loan B facility.
ICON founded in Dublin, Ireland, by Dr. John Climax & Dr. Ronan Lambe. From a small team of 5 in 1990, ICON now employs over 41,150 people across 95 locations in 45 countries.
